Inactivation of p53 and deletion of ATM in B-CLL patients in relation to IgVH mutation status and previous treatment. [electronic resource]
- Leukemia Jun 2006
- 1159-61 p. digital
Publication Type: Letter; Research Support, Non-U.S. Gov't
0887-6924
10.1038/sj.leu.2404195 doi
Ataxia Telangiectasia Mutated Proteins Cell Cycle Proteins--genetics DNA-Binding Proteins--genetics Female Gene Deletion Genes, Neoplasm Humans Immunoglobulin Heavy Chains--genetics Immunoglobulin Variable Region--genetics Leukemia, Lymphocytic, Chronic, B-Cell--diagnosis Male Middle Aged Point Mutation Protein Serine-Threonine Kinases--genetics Treatment Outcome Tumor Suppressor Protein p53--genetics Tumor Suppressor Proteins--genetics